Tuesday, July 3, 11:26 AMNuance (
NUAN+2.2%) trades higher following
the
purchaseof rival clinical transcription/voice
recognition solutions provider M*Modal (
MODL) by JPMorgan's P-E arm.
Deutsche(Buy) notes the deal's valuation (2x
estimated FY13 sales) is in-line with the that paid by Nuance for
recent acquisitions, and thinks it's evidence
P-E firms are "becoming more active" in the medical transcription
and records space.
Newsletter
Subscribe to our email list for regular free market updates
as well as a chance to get coupons!
NUAN
Posted by morton13 on 3rd of Jul 2012 at 11:35 am
daily
Tuesday, July 3, 11:26 AM Nuance ( NUAN +2.2%) trades higher following the purchaseof rival clinical transcription/voice recognition solutions provider M*Modal ( MODL) by JPMorgan's P-E arm. Deutsche(Buy) notes the deal's valuation (2x estimated FY13 sales) is in-line with the that paid by Nuance for recent acquisitions, and thinks it's evidence P-E firms are "becoming more active" in the medical transcription and records space.